Leyland-Jones, Brian <br/><br/>
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2005 
 - 5960-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.06.150  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia<br/>Breast Neoplasms--drug therapy<br/>Epoetin Alfa<br/>Erythropoietin--adverse effects<br/>Female<br/>Hematinics--adverse effects<br/>Hemoglobins--analysis<br/>Humans<br/>Injections, Subcutaneous<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Placebos<br/>Quality of Life<br/>Recombinant Proteins<br/>Survival Analysis